CeriBell, Inc.
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of pat…
Healthcare
US, Sunnyvale [HQ]
CBLL/Financial Reporting
Income Statements
2 Sheets · Starting from 2022In Million USD. Margins, Growth Rates In %
| Metric | 2022 | 2023 | |
|---|---|---|---|
| Revenue | 25.00 | 45.00 | |
|
EPS
|
-1.59 | -1.27 | |
| Diluted in mil. | -1.59 | -1.27 | |
|
Profit
|
21.00 | 38.00 | |
| Gross Margin | 82.91 | 84.38 | |
| Pre Tax | -37.00 | -29.00 | |
| Profit Margin | -143.36 | -65.13 | |
| ETR | -0.01 | -0.04 | |
| Net | -37.00 | -29.00 | |
| Profit Margin | -143.37 | -65.15 | |
| EBITDA | -35.00 | -26.00 | |
| EBITDA Margin | -135.26 | -58.61 | |
| Operating Income | -36.00 | -30.00 | |
| Operating Margin | -138.96 | -66.43 | |
| Interest Income | - - | - - | |
| Loss | -61.00 | -75.00 | |
| Cost of Revenue | -4.00 | -7.00 | |
|
Operating Expenses
|
-57.00 | -68.00 | |
| R&D | -7.00 | -8.00 | |
| G&A | -18.00 | -20.00 | |
| SG&A | -50.00 | -59.00 | |
| S&M | -31.00 | -38.00 | |
| Depreciation and Amortization | - - | - - | |
| Interest Expenses | -1.00 | -2.00 | |
| Other Expenses | -1.00 | - - | |
|
WA Shares Outstanding
|
23.00 | 23.00 | |
| Diluted | 23.00 | 23.00 |